These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33183167)

  • 1. Molecular modeling approach to identify inhibitors of Rv2004c (rough morphology and virulent strain gene), a DosR (dormancy survival regulator) regulon protein from
    Shanmuga Priya VG; Bhandare V; Muddapur UM; Swaminathan P; Fandilolu PM; Sonawane KD
    J Biomol Struct Dyn; 2022 Apr; 40(7):3242-3257. PubMed ID: 33183167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis DosR regulon gene Rv2004c contributes to streptomycin resistance and intracellular survival.
    Doddam SN; Peddireddy V; Yerra P; Sai Arun PP; Qaria MA; Baddam R; Sarker N; Ahmed N
    Int J Med Microbiol; 2019 Dec; 309(8):151353. PubMed ID: 31521502
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Doddam SN; Peddireddy V; Ahmed N
    Front Immunol; 2017; 8():712. PubMed ID: 28694808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DosR Regulon Modulates Adaptive Immunity and Is Essential for Mycobacterium tuberculosis Persistence.
    Mehra S; Foreman TW; Didier PJ; Ahsan MH; Hudock TA; Kissee R; Golden NA; Gautam US; Johnson AM; Alvarez X; Russell-Lodrigue KE; Doyle LA; Roy CJ; Niu T; Blanchard JL; Khader SA; Lackner AA; Sherman DR; Kaushal D
    Am J Respir Crit Care Med; 2015 May; 191(10):1185-96. PubMed ID: 25730547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of dormancy-related antigens in individuals infected with Mycobacterium tuberculosis in Japan.
    Hozumi H; Tsujimura K; Yamamura Y; Seto S; Uchijima M; Nagata T; Miwa S; Hayakawa H; Fujisawa T; Hashimoto D; Inui N; Suda T; Chida K; Koide Y
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):818-24. PubMed ID: 23676169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rv0807, a putative phospholipase A2 of
    Sundar S; Thangamani L; Manivel G; Kumar P; Piramanayagam S
    J Biomol Struct Dyn; 2020 Aug; 38(13):3990-4004. PubMed ID: 31588859
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycobacterium tuberculosis DosR regulon gene Rv0079 encodes a putative, 'dormancy associated translation inhibitor (DATIN)'.
    Kumar A; Majid M; Kunisch R; Rani PS; Qureshi IA; Lewin A; Hasnain SE; Ahmed N
    PLoS One; 2012; 7(6):e38709. PubMed ID: 22719925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay of PhoP and DevR response regulators defines expression of the dormancy regulon in virulent
    Vashist A; Malhotra V; Sharma G; Tyagi JS; Clark-Curtiss JE
    J Biol Chem; 2018 Oct; 293(42):16413-16425. PubMed ID: 30181216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico analysis of DosR regulon proteins of Mycobacterium tuberculosis.
    Selvaraj S; Sambandam V; Sardar D; Anishetty S
    Gene; 2012 Sep; 506(1):233-41. PubMed ID: 22759512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convergence of Ser/Thr and two-component signaling to coordinate expression of the dormancy regulon in Mycobacterium tuberculosis.
    Chao JD; Papavinasasundaram KG; Zheng X; Chávez-Steenbock A; Wang X; Lee GQ; Av-Gay Y
    J Biol Chem; 2010 Sep; 285(38):29239-46. PubMed ID: 20630871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of
    Kumar N; Srivastava R; Prakash A; Lynn AM
    J Biomol Struct Dyn; 2020 Jul; 38(11):3396-3410. PubMed ID: 31422761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mycobacterium DosR regulon structure and diversity revealed by comparative genomic analysis.
    Chen T; He L; Deng W; Xie J
    J Cell Biochem; 2013 Jan; 114(1):1-6. PubMed ID: 22833514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore model-based virtual screening, docking, biological evaluation and molecular dynamics simulations for inhibitors discovery against
    Naz S; Farooq U; Khan S; Sarwar R; Mabkhot YN; Saeed M; Alsayari A; Muhsinah AB; Ul-Haq Z
    J Biomol Struct Dyn; 2021 Feb; 39(2):610-620. PubMed ID: 31937192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria.
    Lin MY; Reddy TB; Arend SM; Friggen AH; Franken KL; van Meijgaarden KE; Verduyn MJ; Schoolnik GK; Klein MR; Ottenhoff TH
    Infect Immun; 2009 Nov; 77(11):5071-9. PubMed ID: 19737909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique Regulation of the DosR Regulon in the Beijing Lineage of Mycobacterium tuberculosis.
    Domenech P; Zou J; Averback A; Syed N; Curtis D; Donato S; Reed MB
    J Bacteriol; 2017 Jan; 199(2):. PubMed ID: 27799329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium tuberculosis growth following aerobic expression of the DosR regulon.
    Minch K; Rustad T; Sherman DR
    PLoS One; 2012; 7(4):e35935. PubMed ID: 22558276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy.
    Leistikow RL; Morton RA; Bartek IL; Frimpong I; Wagner K; Voskuil MI
    J Bacteriol; 2010 Mar; 192(6):1662-70. PubMed ID: 20023019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screening to identify novel potential inhibitors for Glutamine synthetase of
    Kumari M; Subbarao N
    J Biomol Struct Dyn; 2020 Oct; 38(17):5062-5080. PubMed ID: 31755360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carfilzomib as a potential inhibitor of NADH-dependent enoyl-acyl carrier protein reductases of
    Mahfuz AMUB; Stambuk Opazo F; Aguilar LF; Iqbal MN
    J Biomol Struct Dyn; 2022 Jun; 40(9):4021-4037. PubMed ID: 33251968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
    Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
    J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.